MENU
+Compare
ANIX
Stock ticker: NASDAQ
AS OF
Apr 2, 04:59 PM (EDT)
Price
$2.81
Change
+$0.08 (+2.93%)
Capitalization
87.9M

ANIX Anixa Biosciences Forecast, Technical & Fundamental Analysis

Anixa Biosciences Inc a cancer-focused biotechnology company, develops vaccines and therapies that are focused on critical unmet needs in oncology... Show more

ANIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for ANIX with price predictions
Apr 01, 2025

ANIX in upward trend: price may ascend as a result of having broken its lower Bollinger Band on April 01, 2025

ANIX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 38 cases where ANIX's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ANIX advanced for three days, in of 240 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on March 31, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on ANIX as a result. In of 98 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for ANIX turned negative on March 31, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at .

ANIX moved below its 50-day moving average on March 31, 2025 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ANIX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for ANIX entered a downward trend on March 20, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ANIX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.157) is normal, around the industry mean (13.458). P/E Ratio (0.000) is within average values for comparable stocks, (64.587). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.867). Dividend Yield (0.000) settles around the average of (0.025) among similar stocks. P/S Ratio (384.615) is also within normal values, averaging (251.391).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ANIX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
ANIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

ANIX is expected to report earnings to fall 3.89% to -8 cents per share on March 31

Anixa Biosciences ANIX Stock Earnings Reports
Q1'25
Est.
$-0.09
Q4'24
Missed
by $0.01
Q3'24
Est.
$-0.10
Q2'24
Beat
by $0.01
Q1'24
Missed
by $0.01
The last earnings report on January 01 showed earnings per share of -9 cents, missing the estimate of -8 cents. With 25.97K shares outstanding, the current market capitalization sits at 87.90M.
A.I. Advisor
published General Information

General Information

a developer of non-invasive blood tests for the early detection of solid tumor based cancers

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Computer Peripherals
Address
3150 Almaden Expressway
Phone
+1 408 708-9808
Employees
5
Web
https://www.anixa.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NRILY34.001.61
+4.96%
Nomura Research Institute Ltd.
LLKKF0.02N/A
N/A
Lake Resources N.L.
STRNY32.88-0.14
-0.41%
Severn Trent PLC
XERI0.01N/A
-1.43%
Xeriant, Inc.
BKRKY11.93-0.18
-1.49%
Bank Rakyat

ANIX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ANIX has been loosely correlated with RYTM. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if ANIX jumps, then RYTM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANIX
1D Price
Change %
ANIX100%
-4.55%
RYTM - ANIX
33%
Loosely correlated
-5.61%
PRTA - ANIX
31%
Poorly correlated
-5.13%
DNLI - ANIX
29%
Poorly correlated
-9.60%
SGMO - ANIX
29%
Poorly correlated
-13.07%
CDTX - ANIX
27%
Poorly correlated
-12.16%
More